337 related articles for article (PubMed ID: 8777500)
1. Schizophrenia: recent advances in psychopharmacology.
Sharma T
Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):194-8. PubMed ID: 8777500
[No Abstract] [Full Text] [Related]
2. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
3. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
[No Abstract] [Full Text] [Related]
4. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
5. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-associated retrograde ejaculation.
Jeffries JJ; Vanderhaeghe L; Remington GJ; Al-Jeshi A
Can J Psychiatry; 1996 Feb; 41(1):62-3. PubMed ID: 8919429
[No Abstract] [Full Text] [Related]
7. Management of treatment-resistant patients with schizophrenia.
Marder SR
J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
[TBL] [Abstract][Full Text] [Related]
8. Clozapine versus risperidone in treatment-refractory schizophrenia: possible impact of dosing strategies.
Lane HY; Chang WH
J Clin Psychiatry; 1999 Jul; 60(7):487-8. PubMed ID: 10453806
[No Abstract] [Full Text] [Related]
9. Neuroleptic-induced emesis: a new indication for clozapine?
Bustillo JR; Buchanan RW
Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665
[No Abstract] [Full Text] [Related]
10. New developments in the pharmacological treatment of schizophrenia.
Kane JM
Bull Menninger Clin; 1992; 56(1):62-75. PubMed ID: 1348197
[TBL] [Abstract][Full Text] [Related]
11. [Urinary retention with risperidone].
Siepmann M; Olbrich H
Psychiatr Prax; 1997 Jul; 24(4):209. PubMed ID: 9340666
[No Abstract] [Full Text] [Related]
12. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
13. New antipsychotic medications: do research results relate to clinical practice?
MacEwan GW
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
[TBL] [Abstract][Full Text] [Related]
14. Risperidone response after no clozapine response.
Avnon M; Kunin A
Br J Psychiatry; 1995 Nov; 167(5):699. PubMed ID: 8564340
[No Abstract] [Full Text] [Related]
15. [Clozapine in the treatment of schizophrenia].
Raitasuo V
Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
[No Abstract] [Full Text] [Related]
16. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618
[TBL] [Abstract][Full Text] [Related]
18. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
[No Abstract] [Full Text] [Related]
19. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
[TBL] [Abstract][Full Text] [Related]
20. Acute dystonic reaction with risperidone.
Takhar J; Manchanda R
Can J Psychiatry; 1996 Feb; 41(1):61-2. PubMed ID: 8919428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
